Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China · Delayed Price · Currency is CNY 24.96
+0.85 (3.53%)
Jul 31, 2026, 3:04 PM CST
SHE:300255 Market Cap
SHE:300255 has a market cap or net worth of 22.94 billion as of July 31, 2026. Its market cap has decreased by -39.12% in one year.
Market Cap
22.94B
Enterprise Value
25.41B
Revenue
872.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.96
ChartMarket Cap Chart
Since August 19, 2011, SHE:300255's market cap has increased from 3.35B to 22.94B, an increase of 585.03%. That is a compound annual growth rate of 13.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 22.94B | -59.81% |
| Dec 31, 2025 | 57.07B | 210.66% |
| Dec 31, 2024 | 18.37B | 53.65% |
| Dec 29, 2023 | 11.96B | 137.41% |
| Dec 30, 2022 | 5.04B | -32.60% |
| Dec 31, 2021 | 7.47B | 31.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) | 36.57B |
| Shanghai RAAS Blood Products | 34.15B |
| Suzhou Zelgen Biopharmaceuticals | 32.32B |
| Chongqing Zhifei Biological Products | 31.22B |
| Beijing Tiantan Biological Products | 25.37B |
| Hualan Biological Engineering | 24.54B |
| Xiamen Amoytop Biotech | 23.82B |
| Yili Chuanning Biotechnology | 19.47B |